Zvika Slovin

Zvika Slovin currently serves as President of hylabs (Hy Laboratories Ltd) since November 2024 and holds board memberships at BioGenCell LTD, focusing on regenerative cell therapy, and Curesponse, a leader in precision oncology. Slovin has been the Chair of the Board of Directors at several companies, including SoniVie Ltd, which specializes in renal denervation and was acquired by Boston Scientific, and Human Xtensions, recognized for its handheld surgical robot that is FDA and CE cleared. Additionally, Slovin chaired the Board of Directors at Nobio Bioprotection, which produces FDA-approved dental bio-nano-material, and coramaze technologies GmbH, known for its trans-catheter tricuspid valve repair system. Other notable positions include board memberships at GrayMatters Health, which offers a PTSD treatment platform, and Beyeonics Vision Ltd, a leader in ophthalmology AR/VR surgical navigation systems. Zvika Slovin holds an education from The Hebrew University of Jerusalem.